HomeAI · summaries
Storia in 5 fonti
How Trump's psychedelics executive order could unlock stalled cannabis reform
The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and ibogaine.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Trump signs order to speed review of psychedelics, including the controversial drug ibogaine
Ibogaine is banned under the federal government's most restrictive category for illegal, high-risk drugs.
- ·
scmp.com
Trump signs order to speed up review of psychedelics
This would expedite review of drugs such as ibogaine, a drug that US military veteran groups have said can help treat PTSD.
- ·
upi.com
Trump signs order to speed research on psychedelics for mental health - UPI.com
President Donald Trump signed an executive order Saturday to accelerate research for some psychedelic drugs to treat mental health disorders.
- ·
theguardian.com
Trump announces reforms to accelerate access to psychedelic drug treatments
President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaine
- ·
forbes.com
Psychedelic Stocks Rally After Trump’s Executive Order
One analyst applauded Trump’s order as an “official stamp of validation” for psychedelics.
- ·
Three psychedelics stocks surge after Trump executive order. Oppenheimer sees more upside ahead
Some psychedelic stocks can rally after the executive order on the use of the this type of drug for mental health, Oppenheimer said.
- ·
How Trump's psychedelics executive order could unlock stalled cannabis reform
The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and ibogaine.